Jan Ulbrecht is an Endocrinology/Metabolic physician affiliated with Pennsylvania State University. OpenAlex indexes 107 publications with 6,968 citations (h-index 47).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1850 E Park Ave
Suite 312
State College, PA 168036706
Telephone
814-689-3156Registry record last updated 15 Dec 2015.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Insulet CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Hormonal (systemic)
42.4%l-Thyroxine33.4%Levothyroxine Sodium81%Synthroid11%Tirosint4%Euthyrox2%Levoxyl1%Part D<11 patientsThyroid Hormone Synthesis Inhibitor4.2%Methimazole100%Part D≥35 patients+ 5 more classes in this area
Metabolism & gastrointestinal
33.1%Insulin Analog11.5%Lantus Solostar19%Novolog12%Novolog Flexpen12%Tresiba Flextouch U-10012%Toujeo Max Solostar10%Humalog Kwikpen U-1008%Insulin Lispro Kwikpen U-1006%Lantus6%Basaglar Kwikpen U-1004%Humalog Kwikpen U-2004%Toujeo Solostar4%Humalog3%Part D<11 patientsGLP-1 receptor agonist7.2%Ozempic53%Trulicity27%Mounjaro21%Part D≥22 patients+ 7 more classes in this area
Cardiovascular
13.7%Statin4.8%Atorvastatin Calcium79%Rosuvastatin Calcium21%Part D<11 patientsPCSK9 Inhibitor2.3%Repatha Sureclick100%Part D≥11 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2009 per NIH RePORTER. The latest:
- SHADE - STRESS, HEALTH AND DIABETES EXPERIENCE
Pennsylvania State Univ Hershey Med Ctr
FY2009$79,039M01RR010732 - WRITING AND THE DAILY EXPERIENCE OF ILLNESS
Pennsylvania State Univ Hershey Med Ctr
FY2009$18,951M01RR010732 - TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES PHASE 1
Pennsylvania State Univ Hershey Med Ctr
FY2009$11,093M01RR010732
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramin Zand, MD, MPH
Pennsylvania State University
Allan Lipton, MD
Pennsylvania State University
Steven Ettinger, MD
Pennsylvania State University
Gerald Naccarelli, MD
Pennsylvania State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”